Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by JamesNeven1983on Dec 01, 2019 11:07pm
46 Views
Post# 30411862

RE:RE:Glad I bought the warrants

RE:RE:Glad I bought the warrantsI got the B warrants too .. and I am greatful lol
Jack4000 wrote: Had about 400 k of the A’s I have been wanting to sell and convert to Bs knowing I would have to take a two for one hit or something similar. Just didn’t get around to it. 

Friday I couldn’t believe what I saw- As at 1 1/2 and Bs at 1 and ask at 1 1/2 with 70 on the bid. It was around 3:15 and I knew I had to act fast. I immediately put in a bid for 300 k at one cent knowing I’d have to go to one and one half then went about liquidation my As in various accounts at market (1). 

I checked back back in my cash account and the order for 300 k of the Bs was filled at one cent!  

So, I put in orders for one cent good till Tuesday on my various accounts. Probably have to go one and a half but, I’ve effectively traded my A’s one-for-one for Bs. Very pleased as I thought I may have to go three to one possibly. 

As for the strange abnormally I can only attribute it to be B Wt holders who thought last Monday’s wt amendment meant the Bs rather than the debenture wts and because of the clawback of the lifespan, freaked and deemed the A’s to be of greater value even though its strike is almost times as high.  

Thank you for the wts former B wt holders - whomever you are!!!


Bullboard Posts